Cancerresearchanalytics. 6-Dec-16 | AstraZeneca 5-Dec-16 | Roche 5-Dec-16 | Bristol-Myers Squibb Company 5-Dec-16 | Bristol-Myers Squibb Company 5-Dec-16...
Never miss Cancerresearchanalytics.com updates: Start reading the news feed of Cancerresearchanalytics right away! This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Cancerresearchanalytics.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.
News, stories and media buzz related to Cancerresearchanalytics
-
Approved Drugs > Hematology/Oncology (Cancer) Approvals & Safety Notificationsvia
elbiruniblogspotcom.blogspot
Approved Drugs > Hematology/Oncology (Cancer) Approvals & Safety Notifications FDA granted accelerated approval to olaratumab (LARTRUVO, Eli Lilly and Company) for the treatment of patients with soft tissue sarcoma (STS) not amenable to curative...
-
It’s Going To Be A Bumpy Ride For Biotechvia
etfdailynews
Biotech stocks sailed into 2014 backed by a favorable wind, but springtime has stymied the sector in confused seas. Companies on The Life Sciences Report’s 2014 Biotech Watchlist have hit the doldrums along with the rest, as faithful...
-
Bristol-Myers Squibb announced promising results from an expanded phase 1 dose-ranging study of its lung cancer drug niv...via
newdrugapprovals.wordpress
NIVOLUMAB Anti-PD-1;BMS-936558; ONO-4538 PRONUNCIATION nye vol’ ue mab THERAPEUTIC CLAIM Treatment of cancer CHEMICAL DESCRIPTION A fully human IgG4 antibody blocking the programmed cell death-1 receptor (Medarex/Ono Pharmaceuticals/Bristol...
-
Deals of the Week: Value Surprise!via
invivoblog.blogspot
There’s a lot of talk about valuation these days. Sort of like the porridge in the nursery tale, it’s either too high, or it’s too low, but it’s almost never just right. Start-ups and micro-caps are frequently valued on the strength...
-
Leukemia Therapeutics- Stem cell therapy and bone marrow transplant are the emerging trends and are expected to boost th...via
chris55.edublogs
Leukemia is a type of blood cancer resulting in the abnormal production of blood cells, generally leukocytes (white blood cells). These abnormal cells crowd the bone marrow and other organs such as liver, spleen, and kidneys through blood and prevent...
You may also like
Managing Myeloma is an educational initiative dedicated to developing tools, information, and resources that support improved ther...
True Engrossment of Reader is Real Profession of...
True Engrossment of Reader is Real Profession of a Writer.
ALECENSA® (alectinib) and Information...
Find information for patients about treatment with ALECENSA® (alectinib). See full safety for more information.
Cancerresearchanalytics.com popular pages
-
20-Jun-16 I Adaptimmune Therapeutics plc PHILADELPHIA and OXFORD, United Kingdom, (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today annou...
-
First Presentation of Combination Data for Wnt Inhibitors, Ipafricept and Vantictumab Updated Data for Demcizumab and Tarextumab Also Presented 5-Jun-16 I OncoMed Pharmaceuticals Inc. CHICAGO and REDW...
Some worthy website to observe next
Website parameters
-
8 years
Domain age
-
N/A
Visit duration
-
N/A
Daily visitors
-
N/A
Bounce rate
